Pharma reps transition from hard sell to support

01/9/2012 | Wall Street Journal, The

Some pharma sales representatives are shifting to a more supportive role in the face of industry consolidation, dry pipelines, FDA scrutiny and physician schedules, representatives say. "Increasing physician satisfaction, it turns out, is a much better way to promote a pharmaceutical agent than simply telling them to write more prescriptions or what the benefits [are]," said David Ricks, president of Eli Lilly & Co.'s global business unit. Nonetheless, many doctors refuse to see drug reps, often because they have no time or have had unpleasant experiences with reps, says Chris Wright of ZS Associates.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA